Response of generalized granuloma annulare to high-dose niacinamide
- 1 October 1983
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 119 (10) , 836-839
- https://doi.org/10.1001/archderm.119.10.836
Abstract
A patient with generalized granuloma annulare experienced resolution of her lesions after 6 mo. of treatment with 1500 mg/day of niacinamide. Niacinamide seems to be a reasonably safe drug that, even at relatively high doses, is associated with a low incidence of side effects. The participation of a delayed hypersensitivity reaction in the pathogenesis of granuloma annulare and possible mechanisms involving niacinamide in this type of reaction are discussed.This publication has 7 references indexed in Scilit:
- Erythematous generalized granuloma annulareArchives of Dermatology, 1979
- Disseminated granuloma annulare treated with low-dose chlorambucilArchives of Dermatology, 1979
- Response of generalized granuloma annulare to alkylating agentsArchives of Dermatology, 1978
- Histologic, ultrastructural and histochemical studies of granuloma annulareArchives of Dermatology, 1977
- Lymphokines (MIF) in the serum of patients with sarcoidosis and cutaneous granuloma annulareBritish Journal of Dermatology, 1976
- Nicotinamide: Suppression of Lymphocyte Transformation with a Component Identified in Human Transfer FactorThe Journal of Immunology, 1976
- Generalized granuloma annulare. A report of a case and review of the literatureArchives of Dermatology, 1967